mdma — Podcast — Psychedelic Medicine Podcast

Can Your Genes Predict Response to MDMA Therapy? with Dr. Dave Rabin MD, PhD

In this episode of the Psychedelic Medicine Podcast, Dr. David Rabin, MD, PhD joins to discuss whether genes can be predictive of one’s response to MDMA Therapy. Dr. Rabin, a board-certified psychiatrist and neuroscientist, is the co-founder & chief medical officer at Apollo Neuroscience. In addition to his clinical psychiatry practice, Dr. Rabin is also the co-founder & executive director of The Board of Medicine, and a psychedelic clinical researcher currently evaluating the mechanism of psychedelic-assisted psychotherapy in treatment-resistant mental illnesses.

Plant Medicine.orgAugust 7, 2024mdma

MDMA-Assisted Couples Therapy with Kayla Knopp, PhD

In this episode of the Psychedelic Medicine Podcast Kayla Knopp joins to explore the topic of MDMA-Assisted Couples Therapy. Dr. Kayla Knopp is a clinical psychologist and researcher specializing in non-traditional couples and relationships. She specializes in making couple therapies more inclusive, accessible, and effective, including MDMA- and ketamine-assisted couple therapy.

Plant Medicine.orgMarch 13, 2024mdma

MDMA-Assisted Psychotherapy for Alcohol Use Disorder with Dr. Ben Sessa

In this episode of the Psychedelic Medicine Podcast, Dr. Ben Sessa joins to share results of his investigation into MDMA-assisted psychotherapy for alcohol use disorder. Dr. Sessa is a trained MDMA and psilocybin therapist and the chief medical officer at Awakn Life Sciences, a biotechnology company researching, developing, and commercializing therapeutics to treat addiction with specific attention on alcohol use disorder in the near-term.

Plant Medicine.orgSeptember 14, 2022mdma

MDMA-Assisted Therapy for PTSD with Rick Doblin, PhD

In this episode of the Psychedelic Medicine Podcast (formerly the Plant Medicine Podcast), Rick Doblin joins to discuss the past, present, and future of MDMA-assisted therapy. Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies. He received his doctorate in public policy from Harvard and has also studied under the father of transpersonal psychology Stanislav Grof. Through MAPS, Rick aspires to develop legal contexts for beneficial uses of psychedelics and marijuana as prescription medicines, but also for self-development and personal growth in otherwise healthy individuals.

Plant Medicine.orgJanuary 5, 2022mdma

Becoming an MDMA-Assisted Therapist with Shannon Carlin, MA, LMFT

This episode of the Plant Medicine Podcast features a conversation with Shannon Carlin, MA, LMFT, to discuss how to become an MDMA-assisted therapist, including a discussion of the MAPS training program. Shannon is the Director and Head of Training and Supervision at the MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a 501(c)(3) non-profit where she oversees the development and implementation of clinical training programs that prepare mental health and medical professionals to deliver MDMA-assisted psychotherapy in approved clinical settings. Shannon started working with MAPS in 2011 before joining MAPS PBC in 2016.

Plant Medicine.orgMarch 3, 2021mdma

CBD Beyond the Basics with Hunter Land

In this episode, Dr. Malcolm discusses how antidepressants react with MDMA, psilocybin, DMT, 5-MeO-DMT, ayahuasca, and ketamine. He also explains the risk profiles for interactions between psychedelics and medications such as benzodiazepines, sleep medication, antipsychotics, and lithium.

Plant Medicine.orgSeptember 2, 2020mdma, DMT, 5-MeO-DMT, ayahuasca, Ketamine

Antidepressants and Psychedelics with Clinical Pharmacist Ben Malcolm, PharmD

In this episode, Dr. Malcolm discusses how antidepressants react with MDMA, psilocybin, DMT, 5-MeO-DMT, ayahuasca, and ketamine. He also explains the risk profiles for interactions between psychedelics and medications such as benzodiazepines, sleep medication, antipsychotics, and lithium.

Plant Medicine.orgAugust 26, 2020mdma, DMT, 5-MeO-DMT, ayahuasca, Ketamine

MDMA History and Legality with Natalie Ginsberg

Natalie Ginsberg is the director of policy and advocacy at the Multidisciplinary Association for Psychadelic Studies (MAPS). She works hard to disentangle science from political partisanship on Capitol Hill, the United Nations, and beyond. Today, she is joining us to discuss the history and current legality of MDMA.

Plant Medicine.orgJanuary 8, 2020mdma

MDMA Practitioner Methods with Shannon Carlin

Shannon Carlin is the associate director of training and supervision at the MAPS Public Benefit Corp. In this role, she oversees the development and implementation of the programs that prepare mental health and medical professionals to deliver MDMA assisted psychotherapy in approved clinical settings.

Plant Medicine.orgJanuary 2, 2020mdma

MDMA Scientific Research with Marcela Ot'alora

Marcela Ot'alora G is a psychotherapist with over 20 years of experience working with trauma, specifically PTSD. Having dedicated her professional life to teaching and research, Marcela has served as principle investigator and therapist on various phase-II and phase-III MDMA assisted psychotherapy studies.

Plant Medicine.orgDecember 18, 2019mdma

MDMA Patient Experience with Steven

In today’s patient experience episode, Steven tells us about a therapeutic use of MDMA that you may not have heard of. A medical practitioner himself, Steven understands his own condition of IBS very well and what standard treatment is. However, when all these failed to produce results, Steven took the chance and set out to discover how he could better treat his condition.

Plant Medicine.orgDecember 11, 2019mdma